Is TGF-β1 a Biomarker of Huntington’s Disease Progression?

Huntington’s disease (HD) is an autosomal dominant genetic disease that can be divided into preclinical and symptomatic stages. Due to the diverse HD phenotype, there is an urgent need to identify markers that would independently assess its severity. The aim of this study was to evaluate the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Plinta, Klaudia, Plewka, Andrzej, Wójcik-Pędziwiatr, Magdalena, Zmarzły, Nikola, Rudziński, Marcin, Rudzińska-Bar, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269288/
https://www.ncbi.nlm.nih.gov/pubmed/34279486
http://dx.doi.org/10.3390/jcm10133001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269288/
https://www.ncbi.nlm.nih.gov/pubmed/34279486
http://dx.doi.org/10.3390/jcm10133001

Ejemplares similares